about
Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cellsThe role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis CNatural history of chronic hepatitis CIron availability affects West Nile virus infection in its mosquito vectorMeasurement of liver fat fraction and iron with MRI and MR spectroscopy techniques.Platelet count increase following phlebotomy in iron overloaded patients with liver cirrhosis.Impact of cigarette smoking on response to interferon therapy in chronic hepatitis C Egyptian patientsThe role of iron in the pathophysiology and treatment of chronic hepatitis C.The haemochromatosis gene: a co-factor for chronic liver diseases?Coinfection with HIV-1 alleviates iron accumulation in patients with chronic hepatitis C virus infection.The influence of host factors on the natural history of chronic hepatitis C viral infections.Influence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C.Iron and thiols as two major players in carcinogenesis: friends or foes?Treatment of chronic hepatitis C virus infection.Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection.Quantification of hepatic iron concentration in chronic viral hepatitis: usefulness of T2-weighted single-shot spin-echo echo-planar MR imagingThe hepatologist in the haematologists' camp.Hepatitis C, porphyria cutanea tarda and liver iron: an update.Gender-related variations in iron metabolism and liver diseases.The chelatable iron pool in living cells: a methodically defined quantity.Decreased serum hepcidin concentration correlates with brain iron deposition in patients with HBV-related cirrhosis.Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.Blood transfusion transmitted infections in multiple blood transfused patients of Beta thalassaemia.Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.The history of the "natural history" of hepatitis C (1968-2009).The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection.Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in TaiwanEpoetin alfa for the treatment of combination therapy-induced hemolytic anemia in patients infected with hepatitis C virus.HFE gene in primary and secondary hepatic iron overload.Nutrition therapy for liver diseases based on the status of nutritional intake.Metabolic syndrome is directly associated with gamma glutamyl transpeptidase elevation in Japanese womenThe Role of Iron and Iron Overload in Chronic Liver Disease.Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.Hyperferritinemia is a risk factor for steatosis in chronic liver disease.Haplotype Analysis of Hemochromatosis Gene Polymorphisms in Chronic Hepatitis C Virus Infection: A Case Control Study.Prevalence of anti-HAV antibodies in multitransfused patients with beta-thalassemiaPotential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma.Reduced serum hepcidin levels in patients with chronic hepatitis C.Hepatitis C comorbidities affecting the course and response to therapyThe effect of iron depletion on chronic hepatitis C virus infection.
P2860
Q27489764-03B13D13-6CE5-4FA4-838E-F8FF4629AB32Q28344953-C4B45A0D-6187-49A6-9303-88D15D2F240FQ29620673-AFB54936-785B-40B9-997B-897E643383BAQ30250912-6A7279D3-D0F9-4E93-AB29-D2AA327AB91CQ30667632-819EA034-2483-4962-BD4C-7C93F4ED4DBFQ33349456-E5CB5DDC-180C-4518-BE5B-78DE49BAAE39Q33362712-814F5815-8483-4E0E-A4FC-542C8B124C11Q33586881-BA239344-D401-49F2-A58C-D0A82BEB4C4EQ33731087-83E4E64C-94F9-4674-A206-5FE4C269E1B8Q33753221-5596F276-6F41-43C2-AC52-6B83DC7347EFQ33801341-73C677FC-EA7C-4C1C-BE6F-D8840FFD227FQ33867064-1B7CF548-2588-4D3D-AA26-859BEE22E263Q34042006-4AE5E264-6AD3-4EE2-8B50-552B7C861CFFQ34072137-86A30D83-9922-46B1-A390-1D44A3CEBF88Q34129547-B94B67C4-CCE4-45A1-8746-5A9572B78119Q34206496-6AFD3C14-F35C-4E9C-A7B6-AE11D7148EECQ34266309-0F6F3711-08BC-4EB0-8324-4450CDD73B16Q34268811-7F21BEF0-DF56-4104-BBBD-06FAF2BF7517Q34391646-FD09ED51-BEED-4317-8F57-9FB774B22A55Q34658929-92823FF2-C989-4B26-BB59-C811BEC1EFB4Q34775769-3D2F6B95-DEEA-41DB-B3C3-CC4D1CE98078Q34851479-51F5CE1B-6EAC-4BCE-BDA2-B26269E17C7BQ35106411-23366525-D7D2-442A-A7F1-9F63E06CEA02Q35188613-9BBB209D-A605-40F8-A9F9-37C8A6242722Q35216592-84EDDB14-AE77-4AF0-A419-5FC6E4BB0807Q35590977-4C656F00-E27C-40E5-8F1A-2BE160AAD3A8Q35859008-E9348802-75BE-44A6-80AD-9339326FA0CAQ36146443-F5B835AE-FA06-464C-9A44-2AD2A3703902Q36177897-4F5117AE-31B0-43D7-8037-6E84A42CF892Q36417913-0C1FFB3C-D925-4759-A336-8BB8BAFF6345Q36474639-546FEB8B-D38B-404E-BD17-90985A53E054Q37042599-13AB138B-474D-4037-A89B-92C75DC081B7Q37146192-F8A321D2-CD59-4B95-8C48-03ECD946C414Q37182959-BE2C6FF0-EEC6-4CEB-8224-06BEA5DE2514Q37213062-A60E4D6C-F4EF-43CD-9CB5-B43642B76C6FQ37220874-9C954C5F-3A6F-4F8F-9F40-60192F27AB56Q37324402-8EB3B4A2-905A-4153-930C-0225BB4744C0Q37387659-3A380942-E9E1-4BAC-A85F-DF29655E51FCQ37402438-5F1154A8-278A-46E2-B45F-479B35BD1295Q37577548-150AE814-6611-417E-9FE1-A12E65B4F868
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Iron and chronic viral hepatitis.
@en
type
label
Iron and chronic viral hepatitis.
@en
prefLabel
Iron and chronic viral hepatitis.
@en
P2093
P356
P1433
P1476
Iron and chronic viral hepatitis.
@en
P2093
Bonkovsky HL
Rothman AL
P304
P356
10.1002/HEP.510250345
P407
P577
1997-03-01T00:00:00Z